1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA COL6A3 CTRPv2 pan-cancer AAC -0.099 0.009
mRNA ARHGAP8 CTRPv2 pan-cancer AAC 0.11 0.009
mRNA CEACAM18 CTRPv2 pan-cancer AAC 0.091 0.009
mRNA SIGLEC7 CTRPv2 pan-cancer AAC 0.092 0.009
mRNA MLYCD CTRPv2 pan-cancer AAC 0.093 0.009
mRNA PTK6 CTRPv2 pan-cancer AAC 0.11 0.009
mRNA AKR1B1 CTRPv2 pan-cancer AAC -0.1 0.009
mRNA TPM4 CTRPv2 pan-cancer AAC -0.1 0.009
mRNA CNN1 CTRPv2 pan-cancer AAC -0.093 0.009
mRNA ADIG CTRPv2 pan-cancer AAC 0.089 0.009
Download CSV